Cavalier Jason 4
4 · Lyra Therapeutics, Inc. · Filed Sep 15, 2021
Insider Transaction Report
Form 4
Cavalier Jason
Chief Financial Officer
Transactions
- Award
Stock Options (Right to Buy)
2021-09-13+104,000→ 104,000 totalExercise: $8.22Exp: 2031-09-12→ Common Stock (104,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable as to 25% of the underlying shares on September 13, 2022 and in 36 substantially equal monthly installments thereafter.